Research ArticleArticle
Clinical Extrapolation of the Effects of Dolutegravir and Other HIV Integrase Inhibitors on Folate Transport Pathways
Maciej J. Zamek-Gliszczynski, Xuexiang Zhang, Jennypher Mudunuru, Yewei Du, Jian-Lu Chen, Kunal S. Taskar, Jane Huang, Yong Huang and Elizabeth H. Romach
Drug Metabolism and Disposition August 2019, 47 (8) 890-898; DOI: https://doi.org/10.1124/dmd.119.087635
Maciej J. Zamek-Gliszczynski
GlaxoSmithKline, Collegeville, Pennsylvania (M.J.Z.-G., J.M.); GlaxoSmithKline, Ware, United Kingdom (K.S.T.); BioIVT, Santa Clara, California (X.Z., Y.D., J.-L.C., J.H., Y.H.); and ViiV Healthcare, Research Triangle, North Carolina (E.H.R.)
Xuexiang Zhang
GlaxoSmithKline, Collegeville, Pennsylvania (M.J.Z.-G., J.M.); GlaxoSmithKline, Ware, United Kingdom (K.S.T.); BioIVT, Santa Clara, California (X.Z., Y.D., J.-L.C., J.H., Y.H.); and ViiV Healthcare, Research Triangle, North Carolina (E.H.R.)
Jennypher Mudunuru
GlaxoSmithKline, Collegeville, Pennsylvania (M.J.Z.-G., J.M.); GlaxoSmithKline, Ware, United Kingdom (K.S.T.); BioIVT, Santa Clara, California (X.Z., Y.D., J.-L.C., J.H., Y.H.); and ViiV Healthcare, Research Triangle, North Carolina (E.H.R.)
Yewei Du
GlaxoSmithKline, Collegeville, Pennsylvania (M.J.Z.-G., J.M.); GlaxoSmithKline, Ware, United Kingdom (K.S.T.); BioIVT, Santa Clara, California (X.Z., Y.D., J.-L.C., J.H., Y.H.); and ViiV Healthcare, Research Triangle, North Carolina (E.H.R.)
Jian-Lu Chen
GlaxoSmithKline, Collegeville, Pennsylvania (M.J.Z.-G., J.M.); GlaxoSmithKline, Ware, United Kingdom (K.S.T.); BioIVT, Santa Clara, California (X.Z., Y.D., J.-L.C., J.H., Y.H.); and ViiV Healthcare, Research Triangle, North Carolina (E.H.R.)
Kunal S. Taskar
GlaxoSmithKline, Collegeville, Pennsylvania (M.J.Z.-G., J.M.); GlaxoSmithKline, Ware, United Kingdom (K.S.T.); BioIVT, Santa Clara, California (X.Z., Y.D., J.-L.C., J.H., Y.H.); and ViiV Healthcare, Research Triangle, North Carolina (E.H.R.)
Jane Huang
GlaxoSmithKline, Collegeville, Pennsylvania (M.J.Z.-G., J.M.); GlaxoSmithKline, Ware, United Kingdom (K.S.T.); BioIVT, Santa Clara, California (X.Z., Y.D., J.-L.C., J.H., Y.H.); and ViiV Healthcare, Research Triangle, North Carolina (E.H.R.)
Yong Huang
GlaxoSmithKline, Collegeville, Pennsylvania (M.J.Z.-G., J.M.); GlaxoSmithKline, Ware, United Kingdom (K.S.T.); BioIVT, Santa Clara, California (X.Z., Y.D., J.-L.C., J.H., Y.H.); and ViiV Healthcare, Research Triangle, North Carolina (E.H.R.)
Elizabeth H. Romach
GlaxoSmithKline, Collegeville, Pennsylvania (M.J.Z.-G., J.M.); GlaxoSmithKline, Ware, United Kingdom (K.S.T.); BioIVT, Santa Clara, California (X.Z., Y.D., J.-L.C., J.H., Y.H.); and ViiV Healthcare, Research Triangle, North Carolina (E.H.R.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Integrase Inhibitor Effects on Folate Transport
Maciej J. Zamek-Gliszczynski, Xuexiang Zhang, Jennypher Mudunuru, Yewei Du, Jian-Lu Chen, Kunal S. Taskar, Jane Huang, Yong Huang and Elizabeth H. Romach
Drug Metabolism and Disposition August 1, 2019, 47 (8) 890-898; DOI: https://doi.org/10.1124/dmd.119.087635
Research ArticleArticle
Integrase Inhibitor Effects on Folate Transport
Maciej J. Zamek-Gliszczynski, Xuexiang Zhang, Jennypher Mudunuru, Yewei Du, Jian-Lu Chen, Kunal S. Taskar, Jane Huang, Yong Huang and Elizabeth H. Romach
Drug Metabolism and Disposition August 1, 2019, 47 (8) 890-898; DOI: https://doi.org/10.1124/dmd.119.087635
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement